Clinicopathologic characteristics at diagnosis and the survival of patients with medullary breast carcinoma in China: A comparison with infiltrating ductal carcinoma-not otherwise specified

World Journal of Surgical Oncology

Volumn 11, Issue , 2013, Pages

  Cao, A Yong ^a   He, Min ^a   Huang, Liang ^a   Shao, Zhi Ming ^a   Di, Gen Hong ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Clinical outcomes; Medullary breast carcinoma; Tumor characteristics

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RECURRENCE; CANCER SURVIVAL; DISEASE FREE SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFILTRATING DUCTAL CARCINOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, MEDULLARY; CHINA; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84876730988     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-11-91     Document Type: Article

References (21)

1. Pedersen L, Zedeler K, Holck S, Schiødt T, Mouridsen HT. Medullary carcinoma of the breast. Prevalence and prognostic importance of classical risk factors in breast cancer. Eur J Cancer 1995, 31A:2289-2295.
2. Malyuchik SS, Kiyamova RG. Medullary breast carcinoma. ExpOncol 2008, 30:96-101.
3. Cheang MC, Voduc D, Bajdik C, Leung S, McKinney S, Chia SK, Perou CM, Nielsen TO. Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype. Clin Cancer Res 2008, 14:1368-1376. 10.1158/1078-0432.CCR-07-1658, 18316557.
4. de Cremoux P, Salomon AV, Liva S, Dendale R, Bouchind'homme B, Martin E, Sastre-Garau X, Magdelenat H, Fourquet A, Soussi T. p53 mutation as a genetic trait of typical medullary breast carcinoma. J Natl Cancer Inst 1999, 91:641-643. 10.1093/jnci/91.7.641, 10203285.
5. Xu R, Feiner H, Li P, Yee H, Inghirami G, Delgado Y, Perle MA. Differential amplification and overexpression of HER-2/neu, p53, MIB1, and estrogen receptor/progesterone receptor among medullary carcinoma, atypical medullary carcinoma, and high-grade invasive ductal carcinoma of breast. Arch Pathol Lab Med 2003, 127:1458-1464.
6. Samir SM, Fayaz MS, Elbasmi A, Motawy MM, Abuzallouf S, George T, Abdelhady M, Bedair A. Medullary carcinoma of the breast: ten year clinical experience of the kuwait cancer control centre. Gulf J Oncolog 2011, 1:45-52.
7. Jacquemier J, Bertucci F, Finetti P, Esterni B, Charafe-Jauffret E, Thibult ML, Houvenaeghel G, Van den Eynde B, Birnbaum D, Olive D, Xerri L. High expression of indoleamine 2, 3-dioxygenase in the tumour is associated with medullary features and favourable outcome in basal-like breast carcinoma. Int J Cancer 2012, 130:96-104. 10.1002/ijc.25979, 21328335.
8. Martinez SR, Beal SH, Canter RJ, Chen SL, Khatri VP, Bold RJ. Medullary carcinoma of the breast: a population-based perspective. Med Oncol 2011, 28:738-744. 10.1007/s12032-010-9526-z, 20390465.
9. Khomsi F, Ben Bachouche W, Bouzaiene H, Chargui R, Ben Hassouna J, Mtaalah MH, Dhiab T, Hechiche M, Benna F, Boussen H, Gamoudi A, Rahal K. Typical medullary carcinoma of the breast: a retrospective study about 33 cases. Gynecol Obstet Fertil 2007, 35:1117-1122. 10.1016/j.gyobfe.2007.08.022, 17977045.
10. Richardson WW. Medullary carcinoma of the breast; a distinctive tumour type with a relatively good prognosis following radical mastectomy. Br J Cancer 1956, 10:415-423. 10.1038/bjc.1956.48, 2073834, 13396090.
11. Foschini MP, Eusebi V. Rare (new) entities of the breast and medullary carcinoma. Pathology 2009, 41:48-56. 10.1080/00313020802563528, 19089740.
12. Livi L, Meattini I, Saieva C, Borghesi S, Scotti V, Petrucci A, Rampini A, Marrazzo L, Di Cataldo V, Bianchi S, Cataliotti L, Biti G. The impact of young age on breast cancer outcome. Eur J SurgOncol 2010, 36:639-645.
13. Paluch-Shimon S, Wolf I, Sadetzki S, Gluck I, Oberman B, Zvi Papa M, Catane R, Kaufman B. Association between very young age and adverse characteristics of breast cancer at presentation amongst israeli women. Am J ClinOncol 2011, 34:219-222.
14. Bastiaannet E, Liefers GJ, de Craen AJ, Kuppen PJ, van de Water W, Portielje JE, van der Geest LG, Janssen-Heijnen ML, Dekkers OM, van de Velde CJ, Westendorp RG. Breast cancer in elderly compared to younger patients in the Netherlands: stage at diagnosis, treatment and survival in 127,805 unselected patients. Breast Cancer Res Treat 2010, 124:801-807. 10.1007/s10549-010-0898-8, 20428937.
15. Marginean F, Rakha EA, Ho BC, Ellis IO, Lee AH. Histological features of medullary carcinoma and prognosis in triple-negative basal-like carcinomas of the breast. Mod Pathol 2010, 23:1357-1363. 10.1038/modpathol.2010.123, 20581807.
16. Rakha EA, Aleskandarany M, El-Sayed ME, Blamey RW, Elston CW, Ellis IO, Lee AH. The prognostic significance of inflammation and medullary histological type in invasive carcinoma of the breast. Eur J Cancer 2009, 45:1780-1787. 10.1016/j.ejca.2009.02.014, 19286369.
17. Thurman SA, Schnitt SJ, Connolly JL, Gelman R, Silver B, Harris JR, Recht A. Outcome after breast-conserving therapy for patients with stage I or II mucinous, medullary, or tubular breast carcinoma. Int J RadiatOncolBiolPhys 2004, 59:152-159.
18. Vu-Nishino H, Tavassoli FA, Ahrens WA, Haffty BG. Clinicopathologic features and long-term outcome of patients with medullary breast carcinoma managed with breast-conserving therapy (BCT). Int J RadiatOncolBiolPhys 2005, 62:1040-1047.
19. Fisher ER, Kenny JP, Sass R, Dimitrov NV, Siderits RH, Fisher B. Medullary cancer of the breast revisited. Breast Cancer Res Treat 1990, 16:215-229. 10.1007/BF01806330, 2085673.
20. Reinfuss M, Stelmach A, Mitus J, Rys J, Duda K. Typical medullary carcinoma of the breast: a clinical and pathological analysis of 52 cases. J SurgOncol 1995, 60:89-94.
21. Vo T, Xing Y, Meric-Bernstam F, Mirza N, Vlastos G, Symmans WF, Perkins GH, Buchholz TA, Babiera GV, Kuerer HM, Bedrosian I, Akins JS, Hunt KK. Long-term outcomes in patients with mucinous, medullary, tubular, and invasive ductal carcinomas after lumpectomy. Am J Surg 2007, 194:527-531. 10.1016/j.amjsurg.2007.06.012, 17826073.